| 1 |
Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype |
|
| | Dora Fonseca, Adrien Morel, Kevin Llinas-Caballero, David Bolivar-Salazar, Paul Laissue | | | Pharmacogenomics and Personalized Medicine. 2021; Volume 14: 287 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017 |
|
| | Kazeem Adeola Oshikoya, Ibrahim Abayomi Ogunyinka, Comfort Kunak Ogar, Abiodun Abiola, Ali Ibrahim, Ibrahim Adekunle Oreagba | | | Therapeutic Advances in Drug Safety. 2020; 11: 2042098620 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India |
|
| | Niti Mittal,Mahesh Gupta,Mohit Singla | | | Cutaneous and Ocular Toxicology. 2014; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
First reports of serious adverse drug reactions in recent weeks |
|
| | | | | Drugs & Therapy Perspectives. 2012; 28(8): 20 | | | [Pubmed] [Google Scholar] [DOI] | |
|
